VOLITIONRX LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.744 USD | +2.82% |
|
-6.38% | +4.46% |
| 14/05 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
| 13/05 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechScott Powell (Executives)We are VolitionRx. Ticker is VNRX on the New York Sto...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Calendar
02/07/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.7236
USD
Average target price
3.633
USD
Spread / Average Target
+402.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.46% | 59.93M | |
| -27.07% | 9.87B | |
| -16.78% | 2.75B | |
| -17.50% | 2.13B | |
| -25.12% | 1.65B | |
| +65.65% | 1.47B | |
| +31.17% | 811M | |
| -5.02% | 733M | |
| -30.41% | 510M | |
| +0.20% | 300M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- Transcript : VolitionRx Limited Presents at GCFF Virtual Conference – Investing in Innovation, Sep-10-2020 09
